Elasty D and Elasty D Plus are Dongbang Medical HA dermal fillers engineered with PNET™ technology for deep structural support in high-tension facial areas. We supply Elasty D wholesale from Korea as a monophasic cohesive filler with sub-0.2 ppm residual BDDE and a dual-syringe option for clinic economics.
Dongbang Medical's Elasty Deep range occupies a precise position in the HA filler market: a high-G', monophasic cohesive gel engineered for the structural demands of deep dermal and supraperiosteal placements. For clinics that standardise on deep structural correction, nasolabial folds, marionette lines, chin and cheek contouring, an Elasty D bulk order provides consistent clinical outcomes with predictable per-treatment economics.
Yaksu Medi's advantage is positional: we operate from South Korea, within the same supply ecosystem as Dongbang Medical itself. Every unit we export is sourced from documented Korean supply channels, no secondary reseller layer, no inflated landed cost. Clinics in Europe, the Middle East, and the Americas use us to establish a reliable Elasty D wholesale cadence that holds across seasons and market fluctuations.
Yaksu Medi operates within South Korean supply channels tied to Dongbang Medical, ensuring that every Elasty D unit we ship arrives in factory-sealed, unopened packaging. No secondary reseller margin, your procurement cost stays aligned with direct Korean export pricing.
Clinics that upgrade to the 2×1.1 mL dual-syringe configuration reduce their cost-per-treatment without increasing stocking complexity. At 2.2 mL total per procurement unit, a single Elasty D Plus box covers comprehensive multi-zone correction in one session.
The identical HA architecture between Elasty D and Elasty D Plus means clinics can freely mix both variants in a single order for different protocol needs, no separate MOQ per SKU. This simplifies inventory management for high-volume practices.
United Kingdom, Germany, France, Italy, Spain, Poland, Albania
United Arab Emirates (Dubai), Saudi Arabia, Qatar, Kuwait, Turkey
United States, Canada, Mexico, Brazil, Colombia, Argentina
Japan, Thailand, Australia
To request a B2B quote, send your variant requirements and destination country via the WhatsApp button above. For distributor-tier orders or mixed filler portfolio inquiries, mention your expected monthly volume for tailored pricing. See our Dermal fillers wholesale lane for related HA options.
From first inquiry to clinic delivery, here is how an Elasty D wholesale order progresses through our export workflow.
Contact us via WhatsApp specifying Elasty D, Elasty D Plus, or a mixed order. Clarify syringe configuration (1×1.1 mL or 2×1.1 mL) and estimated monthly volume to help us provide precise B2B pricing.
We verify real-time inventory for your requested variants and packaging configurations directly against our South Korean supply channel, confirming availability before any commitment.
A proforma invoice is issued with full product description, quantity, and pricing. Cold-chain packaging requirements for Elasty D are confirmed at this stage.
Upon receipt of payment, we initiate export preparation. Elasty D is packaged with temperature-controlled insulation for air freight, maintaining the 2°C–25°C requirement throughout transit.
Shipments are dispatched via FedEx International Priority, EMS, or dedicated air freight channel depending on order volume and destination. For large distributor orders, sea container routing is available.
Tracking information is shared upon dispatch. After delivery confirmation, we support your next wholesale or bulk order plan, including variant mix adjustments based on clinic feedback.
Both variants share the same PNET™ HA architecture and UTW needle technology. The only structural difference is lidocaine integration. Choose based on your patient comfort protocol and anaesthesia preference, not on HA performance, which is equivalent.
| Variant | Best for | Depth / Area | Needle | Lidocaine | Procurement note |
|---|---|---|---|---|---|
| Elasty D (Standard) | Lidocaine-free protocols, patients with lidocaine sensitivities | Deep dermis / supraperiosteal | 27G & 30G UTW | None (0%) | Single (1×1.1 mL) or dual (2×1.1 mL) box |
| Elasty D Plus (Lidocaine) | Comfort-focused procedures, high-volume sessions | Deep dermis / supraperiosteal | 27G & 30G UTW | 0.3% | Single (1×1.1 mL) or dual (2×1.1 mL) box |
Specs: HA 24 mg/mL · 0% Lidocaine · 1×1.1 mL or 2×1.1 mL · 27G/30G UTW
The pure monophasic cohesive workhorse. High elastic modulus and cohesion deliver structural volume in deep dermal and supraperiosteal planes. Ideal for practitioners who run lidocaine-free protocols or treat patients with lidocaine sensitivities. The dual-syringe (2×1.1 mL) configuration enables full-session pan-facial coverage in a single procurement unit.
Specs: HA 24 mg/mL · 0.3% Lidocaine · 1×1.1 mL or 2×1.1 mL · 27G/30G UTW
Identical HA architecture to Elasty D, enhanced with 0.3% lidocaine for a virtually painless procedure. Trending as the preferred deep filler for high-throughput clinics running multiple deep-plane corrections per session. The integrated anesthetic removes the need for topical prep steps and consistently improves patient-reported comfort scores.
The following documents are provided by Dongbang Medical. They cover the full Elasty range, clinical data, rheological benchmarks, and regulatory compliance detail.
Full manufacturer clinical e-book covering the complete Elasty portfolio: technology foundation, rheological data, procedural guidance, and application protocol.
Download E-Book (PDF)Quantitative precision and safety data for the Elasty range including BDDE residual measurement, cross-linking density benchmarks, and comparative performance analysis.
Download Clinical Data (PDF)Counterfeit HA fillers pose a direct patient safety risk. Dongbang Medical employs a multi-layer anti-counterfeiting system. Use these four verification steps on every received shipment.
Every Elasty D box ships with Dongbang Medical's laser-engraved holographic seal. The seal reveals a "VOID" message on any breach attempt, unambiguous proof of original, factory-sealed packaging.
Cross-reference the lot number and expiry date printed on the carton. Ensure the lot information is consistent between the outer carton and the individual syringe label, mismatches are a common indicator of non-original product.
Inspect syringe colour coding, needle gauge labelling, and product name format on both the inner syringe label and the outer carton. Counterfeit products consistently fail on one or more of these visual checks.
The ELASTY brand represents the pinnacle of HA filler innovation from Dongbang Medical, a global powerhouse in medical device manufacturing established in 1982. With four decades of specialization in precision needle technology, bio-absorbable sutures, and cannulas, Dongbang Medical developed Elasty to address a specific clinical gap: the biomechanical restoration of tissue integrity at deep anatomical planes.
The brand name is a deliberate acronym, Elasticity by Leading, Acceptable and Safe Treatment for Your Beauty. This shifts the clinical objective from simple augmentation to comprehensive structural re-volumization: recovering what time and metabolic activity erodes from the deep dermis and subcutaneous architecture.
Elasty D occupies the mid-tier of the range between the superficial Fine (F) and the bone-level Grand (G) lines. It is the default choice for clinicians tackling nasolabial folds, marionette lines, chin definition, and high-volume lip augmentation requiring structural, not just superficial, support.
Traditional HA cross-linking relies on high BDDE concentrations to achieve gel stability. This raises the Modification Degree (MoD), the proportion of chemically altered HA chains, which correlates directly with delayed inflammatory response risk.
Elasty's PNET™ (Preserved Natural Entanglement Technology) solves this paradox through a four-stage refinement cycle:
| Factor | Traditional Cross-Linking | PNET™ Technology (Elasty) |
|---|---|---|
| BDDE Efficiency | Often requires high volumes for stability | Nearly 100% participation, highly efficient |
| Residual BDDE | Risk of unlinked / open-chain BDDE | < 0.2 ppm (10× stricter than FDA threshold) |
| Gel Stability | Susceptible to early enzymatic degradation | High resistance, 8–12 months clinical persistence |
| Clinical Profile | Higher potential for late-onset DIR | High biocompatibility; low Modification Degree |
The PNET™ process optimises three biophysical parameters critical to deep-plane filler performance:
Elasty D's high G' and cohesive monophasic structure prevent spreading into unintended tissue planes. It is mapped specifically for deep dermal and supraperiosteal layers where resistance to skin tension is the primary requirement.
Deep creases from nose to mouth require a gel that holds position under high facial tension. The linear threading technique with Elasty D creates a continuous structural strut that provides predictable lift lasting the full clinical duration.
Correcting folds at the oral commissures while preventing product migration in a high-movement facial zone. Elasty D's cohesion ensures anatomical definition remains precise without the lateral spread seen in lower-G' fillers.
Unlike the Fine line used for superficial hydration, Elasty D provides the structural lift required for volume-intensive techniques such as the Russian Lip. The vermilion border remains sharply defined and does not migrate with repetitive movement.
Serial puncture applications in the malar region and along the chin profile deliver the projection and structural definition required for comprehensive facial contouring, without the over-correction risk associated with high-particle-size fillers placed too superficially.
Moderate horizontal forehead lines and supraorbital volume loss are addressable with Elasty D placed in the deep dermis using conservative volumetric deposits. The low injection force (10–20 N) supports controlled, precise delivery in this more sensitive anatomical zone.
Elasty D's safety profile is grounded in two reinforcing layers: an aggressive dual purification process and comprehensive international regulatory approval. While the global FDA benchmark permits up to 2 ppm of residual cross-linked BDDE, Elasty consistently achieves levels below 0.2 ppm, a tenfold increase in purity that directly reduces late-onset inflammatory risk.
The Regulatory Trifecta:
Dongbang Medical's 30-year heritage in micro-polishing extends to the UTW (Ultra Thin Wall) needles included with every Elasty D box. The larger internal diameter of UTW needles allows high-viscosity gel to flow smoothly at lower injection pressure, reducing tissue trauma, bruising, and clinician hand fatigue without requiring gauge downgrades.
The biomechanical stability of Elasty D supports structurally controlled correction in areas subject to constant facial tension. The following before-and-after visual examples illustrate the type of improvement clinics plan for when stocking Elasty D.
MOQ varies by destination and variant configuration. Contact us via WhatsApp with your required variant (Elasty D, Elasty D Plus), syringe format (single or dual), and approximate monthly volume, we will provide a tailored B2B pricing proposal.
Yes. Mixed orders combining both variants and packaging configurations are standard. Since the HA architecture is identical, there is no separate MOQ per variant, your full order is treated as a single procurement event.
Elasty D requires storage between 2°C and 25°C. We use temperature-controlled insulated packaging for all air freight shipments. FedEx International Priority and EMS are our primary carriers; sea container routing is available for large distributor volumes.
We export to the United States, Canada, United Kingdom, Germany, Poland, France, Italy, Spain, Albania, UAE, Saudi Arabia, Qatar, Kuwait, Turkey, Brazil, Colombia, Argentina, Mexico, Thailand, Japan, and Australia, among others.
Authentic Elasty products carry Dongbang Medical's tamper-evident holographic seal on every carton. The seal reveals a "VOID" pattern if breached. Verify the lot number and expiry date on both the syringe label and outer carton, any mismatch between the two is a red flag.
The standard Elasty D (without lidocaine) carries the CE Mark for EU/EEA distribution. Elasty D Plus (with 0.3% lidocaine) is MFDS (KFDA) approved but does not currently hold CE certification for the lidocaine-integrated version. Both variants are available for export to non-CE-restricted markets.
Both share an identical HA concentration of 24 mg/mL and the same PNET™ cross-linking architecture. The only difference is Elasty D Plus contains 0.3% lidocaine for patient comfort during injection. Clinical practitioners with lidocaine-sensitive patients, or those preferring manual anaesthesia protocols, typically choose Elasty D Standard.
Both Elasty D and Elasty D Plus are available in single-syringe (1×1.1 mL) and dual-syringe (2×1.1 mL) configurations. The dual-syringe box provides 2.2 mL total per procurement unit, the preferred format for high-volume clinics running multi-area treatments per session, as it reduces cost-per-mL without inflating SKU count.
PNET™ (Preserved Natural Entanglement Technology) is Dongbang Medical's proprietary cross-linking method. By preserving the natural long-chain molecular entanglement of HA, it achieves high elastic modulus and cohesion with minimal BDDE usage. The result is a < 0.2 ppm residual BDDE level, ten times below the FDA threshold of 2 ppm, significantly reducing the risk of delayed inflammatory response.
Clinical persistence is typically 8 to 12 months, depending on patient metabolism, lifestyle factors, and the anatomical depth of placement. The dense 3D cross-linked matrix provides high resistance to endogenous hyaluronidase, extending results beyond many standard HA fillers.
Linear threading is optimal for nasolabial fold correction, creating a continuous structural strut. Serial puncture is preferred for precise volumetric recovery in the chin and malar regions. The UTW (Ultra Thin Wall) needle design allows smooth delivery at 10–20 N injection force, reducing hand fatigue and tissue trauma.
CG Bio Vom Filler is a three-SKU facial HA ladder at 20 mg/mL with lidocaine: Light, Intensive, and Volume. We wholesale the mix from Korea, CE marking announced May 2021.
NeoGenesis Regenovue is a monophasic HA filler at 24 mg/mL in Fine, Deep, and Sub-Q, each with a Plus lidocaine option. We wholesale the six-SKU toolkit from Korea.
Across/Hugel Chaeum Premium is a four-grade HA filler ladder (No.1 to No.4) in dual 1.1 mL syringes with 0.3% lidocaine. We quote mixed-grade MFDS-authorised restock from Korea.